Arch Biopartners Inc. (ARCH)
TSXV
Closed
Aug 26, 2026
Day's Range
0.980052 wk Range
0.3900Overview - ARCH - Arch Biopartners Inc.
Key Statistics
Valuation
Enterprise Value
74.98M
P/E (Trailing)
‪-42.91‬
PEG Ratio
‪1.93‬
Price / Sales (TTM)
‪459.82‬
Price / Book
‪-18.92‬
EV / EBITDA
‪-60.38‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-1,418.63%‬
Return on Assets
‪-276.77%‬
Return on Equity
‪40.00%‬
Ownership
Shares Outstanding
67.72M
Float
53.52M
Held by Insiders
‪18.29%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪1.72‬
50-Day Avg
‪0.8844‬
200-Day Avg
‪0.8524‬
Dividends
Payout Ratio
‪0.00%‬
Peers - ARCH - Arch Biopartners Inc.
Peer Comparison
Compared with companies in Biotechnology listed on TSXV.
- ARCHTSXVArch Biopartners Inc.72.68MMarket Cap-63.11%52-week change-42.92P/E (Trailing)‪0.00%‬Profit Margin
- AURATSXVAuranova Resources Inc.17.73MMarket Cap-156.52%52-week change-1.37P/E (Trailing)‪0.00%‬Profit Margin
- ALTTSXVAlturas Minerals Corp.2.91MMarket Cap+50.00%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- BSTTSXVBessor Minerals Inc.469.28KMarket Cap-50.00%52-week change-2.00P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - ARCH - Arch Biopartners Inc.
About
Arch Biopartners Inc. is a biotechnology company dedicated to the development of innovative healthcare solutions and medical devices. The company focuses primarily on advancing therapeutic products that target inflammation, sepsis, and injury resulting from bacterial infections. A significant aspect of their work…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
